The coronavirus vaccine being developed by AstraZeneca may be facing delays. The British health authority MHRA already gave permission for trials to restart, but the American FDA - where the majority of testing is done - is still dithering, AD reports. The American shutdown could have consequences for when European member states, including the Netherlands who already bought 300 million …
AstraZeneca’s coronavirus vaccine trial was allowed to resume in Britain, but authorities in the U.S. are still investigating the case of a patient who suffered a serious illness. The National Institutes of Health has launched an investigation into the case of a patient who suffered spinal cord damage after joining AstraZeneca’s coronavirus vaccine trial. “Everyone’s hopes are on a vaccine, …
